Issue 5, 2011

Synthesis of Janus type nucleoside analogues and their preliminary bioactivity

Abstract

Novel Janus type nucleoside analogues 1a and 1b were synthesized in seven steps from 2-amino-4,6-dihydroxypyrimidine and 4,6-dihydroxypyrimidine. The base moiety of 1a has one face with a Watson–Crick donor-donor–acceptor (DDA) H-bond array of guanine and the other face with an acceptor-acceptor-donor (AAD) array of cytosine, which might lead to its base pairing with either cytosine or guanine due to the rotating of the glycosyl bond. This property may enable Janus type nucleoside analogues to act as an antiviral compound in a similar way to ribavirin. Both 1a and 1b were screened by a vitroHBV DNA replication inhibition test and indeed 1a showed a great potential with IC50 = 10 μM and SI = 78.9 for antiviral drug development.

Graphical abstract: Synthesis of Janus type nucleoside analogues and their preliminary bioactivity

Supplementary files

Article information

Article type
Paper
Submitted
27 Jul 2010
Accepted
11 Nov 2010
First published
15 Nov 2010

Org. Biomol. Chem., 2011,9, 1516-1522

Synthesis of Janus type nucleoside analogues and their preliminary bioactivity

H. Yang, M. Pan, D. Jiang and Y. He, Org. Biomol. Chem., 2011, 9, 1516 DOI: 10.1039/C0OB00495B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements